← Back to Search

Informational Intervention for Breast Cancer

N/A
Waitlist Available
Led By Judith M Walsh-Cassidy, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to understand study procedures and to comply with them for the entire length of the study
Ability of individual to understand a written informed consent document, and the willingness to sign it
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing a new cancer screening method for older adults. The goal is to learn more about how to help patients and doctors make decisions about cancer screening.

Eligible Conditions
  • Breast Cancer
  • Colorectal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants enrolled at 6 months
Proportion of participants enrolled
Proportion of participants who received an ePrognosis report
+3 more
Other outcome measures
Proportion of patients screened for breast cancer
Proportion of patients screened for colorectal cancer

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Passport to Health booklet, ePrognosis)Experimental Treatment2 Interventions
Participants receive Passport to Health booklet and complete ePrognosis before scheduled primary care visit.
Group II: Arm II (usual care)Active Control2 Interventions
Participants receive usual care before scheduled primary care visit.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,495 Previous Clinical Trials
11,933,094 Total Patients Enrolled
46 Trials studying Breast Cancer
3,828,435 Patients Enrolled for Breast Cancer
Mount Zion Health FundOTHER
12 Previous Clinical Trials
883 Total Patients Enrolled
Judith M Walsh-Cassidy, MDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~21 spots leftby Mar 2025